Navigation Links


Alfa at Biology News

Alfa at Biology Products
Alfa at Biology Technology

Alfalight introduces new 25-watt pump module

The CPM-II is available with 25 watts of output power and a 200-micron (0.22 NA) output fiber for fiber laser applications. A version with 21 watts in a 6+1:1 pump/signal con...

Alfalight awarded $1.7M from Army Research Lab

With the funding, Alfalight will develop pump modules suitable for pumping high-power, fiber-laser sys...

Alfalight receives $4.7M to produce next generation lasers

The goal of the 18-month project, announced Tuesday, is to produce a multi-kilowatt diode laser system for industrial and military applications. The fund...

Nair joins Alfalight; Prill coming to Journal Sentinel interactive media

as vice president of operations. Nair will lead Alfalight's production and engineering teams. He has nearly 20 years of experience in high-volume, high-quality semiconductor manufacturing. Prior to joining Alfalight, he was executive director of wafer fabrication at Maxim Integrated Products and ea...

Alfalight receives $7 million in expansion funding

The financing package was led by GF Private Equity Group, LLC and included all of major previous investors. Those inclu...

More>>

Alfa at Medicine News
Alfa at Medicine Products

Oti Alfa Acetabular liners

Description:...
Company:Encore Medical Corporation

Alfa Tri-Spike

Description:Alfa acetabular cup system has been designed to enhance fixation in the acetabulum with a tri-spiked and cluster hole configurations. The objective of the product design is to minimize micromotion on three primary modes: Tilt, migration and rotation. The Alfa systems advanced design features result in initial and long-term fixation. The porous coating has been chosen for its mean pore size found...
Company:Encore Medical Corporation

Alfa Cluster

Description:Alfa acetabular cup system has been designed to enhance fixation in the acetabulum with a tri-spiked and cluster hole configurations. The objective of the product design is to minimize micromotion on three primary modes: Tilt, migration and rotation. The Alfa systems advanced design features result in initial and long-term fixation. The porous coating has been chosen for its mean pore size found...
Company:Encore Medical Corporation

Allergen, Grass, Alfalfa

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories
Alfa at Medicine Technology

Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

BLOOMFIELD, N.J., July 05, 2007 /PRNewswire/ -- AlfacellCorporation today announced that Lawrence A. Kenyon, executive vicepresident, chief financial officer and corporate secretary, willpresent an overview of the company's product development programsat 8 a.m. EDT on Thursday, July 12, 2007, at the C.E. Unterberg,Towbin Emerging Growth Opportunities Conference in New York. The aud...

In Vitro and In Vivo Data Show Alfacell's Onocanse is Active Against Naive and Chemoresistant Neuroblastoma Cells

Pre-Clinical Results Demonstrate Potential of ONCONASE forTreatment of Neuroblastoma BLOOMFIELD, N.J., June 27, 2007 /PRNewswire-FirstCall/ --Alfacell Corporation today announced that new data show ONCONASE,the company's lead drug candidate, is active against naive andchemoresistant neuroblastoma cells. The pre-clinical in vitro and in vivo data published in CancerLetters (2007; Vo...

Two Phase III clinical trials on corifollitropin alfa (Org 36286) reach randomization target

OSS, the Netherlands, June 27, 2007-Organon, the humanhealthcare business unit of Akzo Nobel, announced today that twoout of three Phase III clinical trials with corifollitropin alfa(Org 36286), a new long-acting fertility hormone, have reachedtheir randomization target. Corifollitropin alfa is a new recombinant fertility hormone. It isthe first of a new class of gonadotropi...

Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival

CHICAGO – June 2, 2007 – Long-term treatment withpegylated interferon alfa-2b in stage III melanoma had asignificant and sustained impact on relapse-free survival (RFS),according to the results of the largest adjuvant trial everconducted in patients with stage III melanoma. Results of the PhaseIII study, led by...

SciClone and Sigma-Tau Report Thymalfasin Meets Primary Endpoint in Phase 2 Malignant Melanoma Trial

-- Data Presented at Annual Meeting of the American Society ofClinical Oncology -- SAN MATEO, Calif. -- June 4, 2007 -- SciClone Pharmaceuticals,Inc. (Nasdaq:SCLN) and Sigma-Tau S.p.A today announced thatSciClone's lead product candidate thymalfasin (ZADAXIN(r), thymosinalpha 1) achieved its primary endpoint in a phase 2 clinical trialtreating patients diagnosed with stage IV malig...

More>>

Other TagsCompetentCompetitiveConjugation
(Date:11/18/2008)...hunting for cancer-related genes and understanding...e-consuming, exercise. At Cold Spring Harbor Labor...now combined their expertise to speed up the rate ... their function in living animals. , The resul...pid, cost-effective genetic screen that in a preli...
(Date:11/18/2008)...re may change fertility, nutritional needs, study ...y News) -- Women who get pregnant after having wei... newborn complications than pregnant women who are... 75 studies. , Data from those studies showed t...ed by 800 percent between 1998 and 2005 (from 12,4...
(Date:11/18/2008)...v. 18 Capital BlueCross received t...ntral PA Chapter of the,Association of Fundraisin...Philanthropy Day on Nov. 17 in Harrisburg. The awa...porations, individuals, foundations and volunteers...ennsylvania, Capital BlueCross,remains part of th...
(Date:11/18/2008)...isfaction Rate with Medicare Drug Coverage , ,...- Ninety-two percent of seniors enrolled in the Me...e satisfied with their coverage according to a nat...cation and advocacy group for older Americans. , ...surveys conducted over the last year found the sam...
Breaking Medicine News(10 mins):Health News:Cold Spring Harbor science teams identify 13 new tumor-suppressor genes in liver cancer 2Health News:Cold Spring Harbor science teams identify 13 new tumor-suppressor genes in liver cancer 3Health News:Cold Spring Harbor science teams identify 13 new tumor-suppressor genes in liver cancer 4Health News:Bariatric Surgery Before Pregnancy Benefits Moms, Babies 2Health News:Capital BlueCross Receives Prestigious Corporation of the Year Award 2Health News:New Survey Shows Seniors Overwhelmingly Satisfied With Medicare Part D 2
(Date:11/18/2008)... more attractive to women seeking short-term relat...l have found. , It was previously assumed that i...cial feature and in non-Western cultures they were...ientists at Liverpool and Stirling University, how...on men attractive and may associate it with health...
(Date:11/18/2008)...meinschaft (DFG, German Research Foundation) is in...researchers. At its autumn meeting in Bonn the Gra...reed to the establishment of 13 additional Researc...search Training Groups. These enable doctoral rese...ties. "We are particularly pleased about the first...
(Date:11/18/2008)...008 The American Journal of Preventive Medicine ...ill be featured at the "Changing Climate Changing...off the event is Guest Editor Howard Frumkin, MD, ... on human health. , "Climate change is a key pub... understand the consequences of climate change for...
(Date:11/17/2008)...008) − A new study confirms that exercise ca...n of neural stem cells in the hippocampus of the m... exercise restores a brain chemical which promotes..., Neural stem cells and progenitor cells differe...have different functions, a process called neuroge...
Breaking Biology News(10 mins):Scientists find facial scars increase attractiveness 2National and international doctoral training 2National and international doctoral training 3National and international doctoral training 4National and international doctoral training 5National and international doctoral training 6National and international doctoral training 7Issues at intersection of climate change and health impact global well-being 2Issues at intersection of climate change and health impact global well-being 3Issues at intersection of climate change and health impact global well-being 4Exercise increases brain growth factor and receptors, prevents stem cell drop in middle age 2Exercise increases brain growth factor and receptors, prevents stem cell drop in middle age 3Daiichi Sankyo Lilly Announce New Prasugrel Head to Head Phase III Study Against Clopidogrel 5434 1Daiichi Sankyo Lilly Announce New Prasugrel Head to Head Phase III Study Against Clopidogrel 5434 2Daiichi Sankyo Lilly Announce New Prasugrel Head to Head Phase III Study Against Clopidogrel 5434 3Daiichi Sankyo Lilly Announce New Prasugrel Head to Head Phase III Study Against Clopidogrel 5434 4Study projects 60 percent increase in ESRD population by 2020 5432 1Study projects 60 percent increase in ESRD population by 2020 5432 2Medivation to Announce Early Positive Data from Phase 1 2 Hormone Refractory Prostate Cancer Trial and Host Conference Call and Webcast on Monday Nov 5430 1Medivation to Announce Early Positive Data from Phase 1 2 Hormone Refractory Prostate Cancer Trial and Host Conference Call and Webcast on Monday Nov 5430 2News from Circulation 3A Journal of the American Heart Association 5428 1News from Circulation 3A Journal of the American Heart Association 5428 2News from Circulation 3A Journal of the American Heart Association 5428 3News from Circulation 3A Journal of the American Heart Association 5428 4
Other Contentsvulgarisichthyosisidiopathicidiopathicidiopathicidiopathicileushemolytichemolytichemolyticimmunizationsimmunizationsimmunizations